CAPhO Connections Podcast - Episode 15 with Kevin Thai

Episode 15: Antineoplastic-Induced Nausea & Vomiting

AINV is a common dose-limiting toxicity that can impact adherence and quality of life. Pharmacists are in an ideal position to optimize management.

Learning Objectives:

• Describe the pathophysiology of AINV

• Apply recommendations from practice guidelines to the treatment of patients with AINV

• Recognize challenges with completing AINV assessment using patient examples

• Explain the importance of the multidisciplinary approach to AINV management

About the Author: Kevin Thai

Kevin obtained his undergraduate pharmacy degree at the University of Alberta in 2017 and worked in community practice for a year before returning to complete a pharmacy residency in oncology with Alberta Health Services Cancer Care. Upon completion, he began practicing on the inpatient hematology/blood and marrow transplant unit at the Foothills Medical Centre in Calgary, Alberta where he currently remains. Beyond direct patient care, Kevin has an interest in improving supportive care practices in oncology and has been involved in several projects reassessing the management of chemotherapy-induced nausea and vomiting.

Resources: 

Information and additional resources mentioned during this episode of the podcast:

• Antiemetics: ASCO Guideline Update | Journal of Clinical Oncology (ascopubs.org)
• SCNAUSEA_Protocol (bccancer.bc.ca)
• Guidelines Detail (nccn.org)
• Prevention of chemotherapy-induced nausea and vomiting in adults - UpToDate
• Management of poorly controlled or breakthrough chemotherapy-induced nausea and vomiting in adults - UpToDate
• BARF – Bringing Antiemetic Recommendations into Future Practice (talentlms.com)